[Patients with psoriasis have an increased risk of cardiovascular diseases].
Psoriasis is a chronic immunoinflammatory disease that affects 2-3% of the population and shares pathophysiologic mechanisms and risk factors with cardiovascular diseases. Studies have suggested psoriasis as an independent risk factor for cardiovascular disease and Danish guidelines on cardiovascular risk factor modification in patients with psoriasis and psoriatic arthritis have recently been published. We provide a short review of the current evidence and the Danish guidelines.
Kardiologisk Afdeling, Gentofte Hospital, Niels Andersens Vej 65, Hellerup. olahha01@geh.regionh.dk
Ole
O
Ahlehoff
Gunnar
G
Gislason
Jesper
J
Lindhardsen
Lone
L
Skov
Peter Riis
PR
Hansen
D018501:Antirheumatic Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000209:etiology / Q000276:immunology; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D003718:Denmark; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000209:etiology / Q000276:immunology; D017410:Practice Guidelines as Topic; D011565:Psoriasis / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D012307:Risk Factors; D054556:Venous Thromboembolism / Q000209:etiology / Q000276:immunology
D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D008727:Methotrexate